Abstract
AbstractWe are developing a new endotamponade for the management of rhegmatogenous retinal detachment (RD). It will be reabsorbable and its efficacy will not be dependent on head posture, being equally effective for superior and inferior RD. This solution will be totally biocompatible and it will not need major changes in the usual pars plana vitrectomy surgical process.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
